Impact of Estrogens Present in Environment on Health and Welfare of Animals

Total Page:16

File Type:pdf, Size:1020Kb

Impact of Estrogens Present in Environment on Health and Welfare of Animals animals Review Impact of Estrogens Present in Environment on Health and Welfare of Animals Konrad Wojnarowski 1,* , Paweł Podobi ´nski 1, Paulina Cholewi ´nska 1 , Jakub Smoli ´nski 1 and Karolina Dorobisz 2 1 Institute of Animal Breeding, Wroclaw University of Environmental and Life Sciences, 51-630 Wroclaw, Poland; [email protected] (P.P.); [email protected] (P.C.); [email protected] (J.S.) 2 Department of Otolaryngology, Head and Neck Surgery, Wrocław Medical University, 50-556 Wrocław, Poland; [email protected] * Correspondence: [email protected] Simple Summary: Estrogens are a group of steroid hormones that recently have gained even more attention in the eyes of scientists. There is an ongoing discussion in the scientific community about their relevance as environmental contaminants and the danger they pose to animal health and welfare. In available literature we can find many examples of their negative effects and mechanisms that are involved with such phenomena. Abstract: Nowadays, there is a growing interest in environmental pollution; however, knowledge about this aspect is growing at an insufficient pace. There are many potential sources of environmental contamination, including sex hormones—especially estrogens. The analyzed literature shows that Citation: Wojnarowski, K.; estrone (E1), estradiol (E2), estriol (E3), and synthetic ethinyloestradiol (EE2) are the most significant Podobi´nski,P.; Cholewi´nska,P.; in terms of environmental impact. Potential sources of contamination are, among others, livestock Smoli´nski,J.; Dorobisz, K. Impact of farms, slaughterhouses, and large urban agglomerations. Estrogens occurring in the environment Estrogens Present in Environment on Health and Welfare of Animals. can negatively affect the organisms, such as animals, through phenomena such as feminization, Animals 2021, 11, 2152. https:// dysregulation of natural processes related to reproduction, lowering the physiological condition of doi.org/10.3390/ani11072152 the organisms, disturbances in the regulation of both proapoptotic and anti-apoptotic processes, and even the occurrence of neoplastic processes thus drastically decreasing animal welfare. Unfortunately, Academic Editors: Edward Narayan, the amount of research conducted on the negative consequences of their impact on animal organisms Alan Tilbrook, Dominique Blache, is many times smaller than that of humans, despite the great richness and diversity of the fauna. Shane Maloney and Jill Fernandes Therefore, there is a need for further research to help fill the gaps in our knowledge. Received: 5 June 2021 Keywords: hormones; welfare; animals; estrogens Accepted: 19 July 2021 Published: 20 July 2021 Publisher’s Note: MDPI stays neutral 1. Introduction with regard to jurisdictional claims in published maps and institutional affil- Currently we can observe a growing interest in the state of the environment, methods iations. of its protection, and the impact that the pollutants present in it have on the health of living organisms. Our knowledge of already present and emerging types of pollution is still expanding, but at an insufficient pace. Sex hormones are one of the groups of pollutants that have recently attracted the attention of scientists. The available literature indicates that the most important of them in terms of environmental impact are hormones belonging Copyright: © 2021 by the authors. to the group of estrogens. Estrogens are a group of sex hormones that include estrone Licensee MDPI, Basel, Switzerland. (E1), estradiol (E2), estriol (E3), estetrol (E4)—produced only during pregnancy, and often This article is an open access article distributed under the terms and synthetic ethinyloestradiol (EE2). Estrogens are also called female hormones and they play conditions of the Creative Commons crucial a role in female organisms, but it should be taken into consideration that they are Attribution (CC BY) license (https:// also necessary for proper functioning of male organisms [1]. creativecommons.org/licenses/by/ Estrogens mainly imply their effects by interaction with isoforms of the estrogen 4.0/). receptor (ER)—ERα and ERβ which then bind these hormones in the cytoplasm of cells Animals 2021, 11, 2152. https://doi.org/10.3390/ani11072152 https://www.mdpi.com/journal/animals Animals 2021, 11, 2152 2 of 16 Animals 2021, 11, 2152 2 of 16 Estrogens mainly imply their effects by interaction with isoforms of the estrogen re- ceptor (ER)—ERα and ERβ which then bind these hormones in the cytoplasm of cells and andtransport transport this complex this complex to the to cell the nucleus. cell nucleus. As a result, As a the result, activation the activation of response of response elements elementsin gene promoters in gene promoters begins the begins transcription the transcription process. Aforementioned process. Aforementioned receptors receptorscan be di- canvided be dividedinto nuclear into nuclearestrogen estrogen receptors receptors (nERs) and (nERs) membrane and membrane estrogen estrogen receptors receptors (mERs). (mERs).Beside the Beside “traditional” the “traditional” estrogen estrogen action, addi action,tional additional ways have ways been have described—influence been described— influencethrough cell through signal cell transduction signal transduction tied with mE tiedRs with rather mERs than rathergenomic than activity genomic process. activity The process.available The literature available discusses literature the discusses differences the differences in the affinity in the and affinity mechanism and mechanism of action ofof actionthese receptors, of these receptors, however, however, as shown as by shown the latest by the studies, latest studies,there is therea high is degree a high of degree func- oftional functional and structural and structural similarity similarity between between mERs mERsand nERs and [2]. nERs Recently, [2]. Recently, additional additional recep- receptors,tors, namely, namely, ER-X ER-X and and Erx Erx were were described described in in the the literature literature but but additional researchresearchon on themthem and and mechanisms mechanisms involved involved with with their their action action are are highly highly advised. advised. ThereThere are are many many potential potential sources sources of contaminationof contamination of the of environmentthe environment with with estrogens, estro- suchgens, as such animal as animal farms, farms, slaughterhouses, slaughterhouses, or large or urbanlarge urban agglomerations agglomerations (Figure (Figure1)[ 3,4 ].1) Estrogens[3,4]. Estrogens present present in excreta, in excreta, due to due natural to natural or artificial or artificial processes processes (like hormone (like hormone therapy ther- or contraception)apy or contraception) contaminate, contaminate, by wastewater by wastewater or fertilization, or fertilization, water and water soil. and An soil. additional An ad- factorsditional determining factors determining the degree the of riskdegree resulting of risk from resulting the presence from the of sexpresence hormones of sex in hor- the environmentmones in the are environment their half-life, are which their varies half-lif dependinge, which onvaries the physico-chemical depending on the conditions, physico- thechemical microbiological conditions, richness the microbiological of contaminated ric watershness of and contaminated soil, from 12 waters h to even and 180 soil, days from in the12 caseh to ofeven water 180 reservoirs days in the without case aof stabilized water reservoirs population without of microorganisms a stabilized population [5]. Removal of ofmicroorganisms estrogen from the[5]. aquatic Removal environment of estrogen is fr important,om the aquatic however, environment it is difficult is toimportant, achieve evenhowever, with it the is usedifficult of modern to achieve filtration even with methods the use [6– of8]. modern As evidenced filtration by methods recent research, [6–8]. As microbialevidenced degradation by recent research, of estrogens microbial can bedegrad led byation many of estrogens bacteria strains can be i.e.,led byRhodococcus, many bac- Novosphingobiumteria strains i.e.,, AcinetobacterRhodococcus,, AgromycesNovosphingobium, and Sphingomonas, Acinetobacter, thus, Agromyces showing, possibleand Sphingo- safe andmonas inexpensive, thus showing ways possible for the reduction safe and ofinexpensive threat involved ways withfor the such reduction pollution of [threat9–13]. in- It isvolved worth with noting such that pollution some fungi, [9–13]. mainly It is worth species noting belonging that some to Aspergillus fungi, mainlygenus species are also be- reportedlonging to performAspergillus aerobic genus degradation are also reported of estrogens to perform [9]. Another aerobic threatdegradation related of to estrogens the pres- ence[9]. Another of hormones threat in therelated aquatic to the environment presence of may hormones be the processes in the aq ofuatic their environment accumulation may in bottombe the processes sediments, of from their which accumulation they can bein releasedbottom sediments, again under from appropriate which they physical can be and re- chemicalleased again conditions under [appropriate9–11]. Another physical factor and of riskchemical can be conditions their bioaccumulation [9–11]. Another in living factor organismsof risk can [ 9be,11 their,14,15 bioaccumulation]. in living organisms [9,11,14,15]. FigureFigure 1. 1.Sources Sources of of estrogens estrogens
Recommended publications
  • Cryptorchidism and Endocrine Disrupting Chemicals ⇑ Helena E
    Molecular and Cellular Endocrinology 355 (2012) 208–220 Contents lists available at SciVerse ScienceDirect Molecular and Cellular Endocrinology journal homepage: www.elsevier.com/locate/mce Review Cryptorchidism and endocrine disrupting chemicals ⇑ Helena E. Virtanen , Annika Adamsson Department of Physiology, University of Turku, Finland article info abstract Article history: Prospective clinical studies have suggested that the rate of congenital cryptorchidism has increased since Available online 25 November 2011 the 1950s. It has been hypothesized that this may be related to environmental factors. Testicular descent occurs in two phases controlled by Leydig cell-derived hormones insulin-like peptide 3 (INSL3) and tes- Keywords: tosterone. Disorders in fetal androgen production/action or suppression of Insl3 are mechanisms causing Cryptorchidism cryptorchidism in rodents. In humans, prenatal exposure to potent estrogen diethylstilbestrol (DES) has Testis been associated with increased risk of cryptorchidism. In addition, epidemiological studies have sug- Endocrine disrupting chemical gested that exposure to pesticides may also be associated with cryptorchidism. Some case–control stud- ies analyzing environmental chemical levels in maternal breast milk samples have reported associations between cryptorchidism and chemical levels. Furthermore, it has been suggested that exposure levels of some chemicals may be associated with infant reproductive hormone levels. Ó 2011 Elsevier Ireland Ltd. All rights reserved. Contents 1. Background.
    [Show full text]
  • Critical Role of Oxidative Stress in Estrogen-Induced Carcinogenesis
    Critical role of oxidative stress in estrogen-induced carcinogenesis Hari K. Bhat*†, Gloria Calaf‡, Tom K. Hei*‡, Theresa Loya§, and Jaydutt V. Vadgama¶ *Department of Environmental Health Sciences, Mailman School of Public Health, 60 Haven Avenue-B1, Columbia University, New York, NY 10032; ‡Center for Radiological Research, Columbia University, New York, NY 10032; and Departments of §Pathology and ¶Medicine, Charles Drew University, Los Angeles, CA 90059 Communicated by Donald C. Malins, Pacific Northwest Research Institute, Seattle, WA, December 27, 2002 (received for review August 22, 2002) Mechanisms of estrogen-induced tumorigenesis in the target quinones generates oxidative stress and potentially harmful free organ are not well understood. It has been suggested that oxida- radicals that are postulated to be required for the carcinogenic tive stress resulting from metabolic activation of carcinogenic process, and analogous to the metabolic activation of hydrocar- estrogens plays a critical role in estrogen-induced carcinogenesis. bons and other nonsteroidal estrogen carcinogens (9, 19–22). We We tested this hypothesis by using an estrogen-induced hamster have investigated the role of oxidative stress in estrogen carci- renal tumor model, a well established animal model of hormonal nogenesis by using a well established hamster renal tumor model carcinogenesis. Hamsters were implanted with 17␤-estradiol (␤E2), that shares several characteristics with human breast and uterine 17␣-estradiol (␣E2), 17␣-ethinylestradiol (␣EE), menadione, a com- cancers, pointing to a common mechanistic origin (6, 9, 23). bination of ␣E2 and ␣EE, or a combination of ␣EE and menadione Different estrogens used in the present study differ in their for 7 months.
    [Show full text]
  • Memorandum Date: June 6, 2014
    DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration Memorandum Date: June 6, 2014 From: Bisphenol A (BPA) Joint Emerging Science Working Group Smita Baid Abraham, M.D. ∂, M. M. Cecilia Aguila, D.V.M. ⌂, Steven Anderson, Ph.D., M.P.P.€* , Jason Aungst, Ph.D.£*, John Bowyer, Ph.D. ∞, Ronald P Brown, M.S., D.A.B.T.¥, Karim A. Calis, Pharm.D., M.P.H. ∂, Luísa Camacho, Ph.D. ∞, Jamie Carpenter, Ph.D.¥, William H. Chong, M.D. ∂, Chrissy J Cochran, Ph.D.¥, Barry Delclos, Ph.D.∞, Daniel Doerge, Ph.D.∞, Dongyi (Tony) Du, M.D., Ph.D. ¥, Sherry Ferguson, Ph.D.∞, Jeffrey Fisher, Ph.D.∞, Suzanne Fitzpatrick, Ph.D. D.A.B.T. £, Qian Graves, Ph.D.£, Yan Gu, Ph.D.£, Ji Guo, Ph.D.¥, Deborah Hansen, Ph.D. ∞, Laura Hungerford, D.V.M., Ph.D.⌂, Nathan S Ivey, Ph.D. ¥, Abigail C Jacobs, Ph.D.∂, Elizabeth Katz, Ph.D. ¥, Hyon Kwon, Pharm.D. ∂, Ifthekar Mahmood, Ph.D. ∂, Leslie McKinney, Ph.D.∂, Robert Mitkus, Ph.D., D.A.B.T.€, Gregory Noonan, Ph.D. £, Allison O’Neill, M.A. ¥, Penelope Rice, Ph.D., D.A.B.T. £, Mary Shackelford, Ph.D. £, Evi Struble, Ph.D.€, Yelizaveta Torosyan, Ph.D. ¥, Beverly Wolpert, Ph.D.£, Hong Yang, Ph.D.€, Lisa B Yanoff, M.D.∂ *Co-Chair, € Center for Biologics Evaluation & Research, £ Center for Food Safety and Applied Nutrition, ∂ Center for Drug Evaluation and Research, ¥ Center for Devices and Radiological Health, ∞ National Center for Toxicological Research, ⌂ Center for Veterinary Medicine Subject: 2014 Updated Review of Literature and Data on Bisphenol A (CAS RN 80-05-7) To: FDA Chemical and Environmental Science Council (CESC) Office of the Commissioner Attn: Stephen M.
    [Show full text]
  • Estetrol: New Perspectives for HRT in Menopause and Breast Cancer
    Graziottin A. Singer C. Kubista E. Visser M. Coelingh Bennink H. Estetrol: new perspectives for HRT in menopause and breast cancer patients V Annual International Congress on Human Reproduction on "Family Reproductive Health", Moscow, Russia, January 18-21, 2011 Estetrol: new perspectives for HRT in menopause and breast cancer patients Alessandra Graziottin *, Christian Singer **, Ernst Kubista **, Monique Visser *** and Herjan J.T. Coelingh Bennink *** * Professor at the University of Florence, Italy – Director, Center of Gynaecology, H San Raffaele Resnati, Milan, Italy ** Akademisches Krankenhaus Wien, Wien, Austria *** Pantarhei Bioscience, Zeist, The Netherlands Estetrol (E 4) is a foetal estrogen, produced by the foetal liver during pregnancy only. It has a selective ERalpha and ERbeta receptor bindin g with preference for ERalpha, with antagonist action. E 4 is present at 9 weeks of gestation, with exponential increase of synthesis and blood levels. At term the foetus produces about 3 mg/day. Elimination half-life is 28 hours. Potential applications in women’s life-span include: contraception, hormone replacement therapy (HRT), specifically for vasomotor symptoms, vulvovaginal atrophy and osteoporosis, and therapy of breast cancer. Preliminary data support its efficacy in the treatment of: hot flushes, with significant reduction; in the maturation of the vaginal mucosa, with significant increase of superficial cells at the cytological evaluation; a dose dependent effect on the endometrium: low doses such as 2 mg of Estetrol/day, sufficient to treat a number of symptoms, do not stimulate the endometrium; a significant protective effect on bone: this growing set of data suggest that E 4 could have a new, significant role in the treatment of menopausal symptoms, with an extraordinary safe profile.
    [Show full text]
  • Estrogen Actions Throughout the Brain
    Estrogen Actions Throughout the Brain BRUCE MCEWEN Harold and Margaret Milliken Hatch Laboratory of Neuroendocrinology, The Rockefeller University, New York, New York 10021 ABSTRACT Besides affecting the hypothalamus and other brain areas related to reproduction, ovarian steroids have widespread effects throughout the brain, on serotonin pathways, catecholaminergic neurons, and the basal forebrain cholinergic system as well as the hippocampal formation, a brain region involved in spatial and declarative memory. Thus, ovarian steroids have measurable effects on affective state as well as cognition, with implications for dementia. Two actions are discussed in this review; both appear to involve a combination of genomic and nongenomic actions of ovarian hormones. First, regulation of the serotonergic system appears to be linked to the presence of estrogen- and progestin-sensitive neurons in the midbrain raphe as well as possibly nongenomic actions in brain areas to which serotonin neurons project their axons. Second, ovarian hormones regulate synapse turnover in the CA1 region of the hippocampus during the 4- to 5-day estrous cycle of the female rat. Formation of new excitatory synapses is induced by estradiol and involves N-methyl-D-aspartate (NMDA) receptors, whereas downregulation of these synapses involves intracellular progestin receptors. A new, rapid method of radioimmunocytochemistry has made possible the demonstration of synapse formation by labeling and quantifying the specific synaptic and dendritic molecules involved. Although NMDA receptor activation is required for synapse formation, inhibitory interneurons may play a pivotal role as they express nuclear estrogen receptor-alpha (ER␣). It is also likely that estrogens may locally regulate events at the sites of synaptic contact in the excitatory pyramidal neurons where the synapses form.
    [Show full text]
  • Interactions of Putative Estrogens with the Intracellular Receptor Complex in Mouse Leydig Cells: Relationship to Preneoplastic Hyperplasia R
    [CANCER RESEARCH 48, 14-18, January 1, 1988) Interactions of Putative Estrogens with the Intracellular Receptor Complex in Mouse Leydig Cells: Relationship to Preneoplastic Hyperplasia R. Lloyd Juriansz,1 Robert A. Huseby, and R. Bruce Wilcox2 Department of Biochemistry, Loma Linda University, Loma Linda, California 92350 ABSTRACT (3), the initial spurt of DNA synthesis occurs independent of pituitary function (6). Actual tumor induction, however, results The interaction of 14 steroidal and nonsteroidal estrogen agonists and from action of unmetabolized estrogen directly upon the Leydig antagonists with the intracellular estrogen receptor system was examined cells (7). These cells in both a susceptible and a nonsusceptible in cell suspensions prepared from the testes of mice that develop malig strain of mouse contain an ER3 complex. The cells from the nant Leydig cell tumors after prolonged estrogen administration. The ability of these substances to stimulate DNA synthesis in short-term (3- two strains differ significantly in that nuclei from susceptible day) studies and to provoke Leydig cell hyperplasia with prolonged (3- animals bind more estrogen, and the proportion of the nuclear mo) administration was also measured. Our data were consistent with ER that remains fixed to the nuclear matrix in solutions of the proposal that, in Leydig cells, the carcinogenic effects of estrogens high salt concentration is greater in the tumor-susceptible ani are mediated through the intracellular receptor complex that results in a mals (8). Furthermore this fraction of the ER increases in localization of hormone bound to chromâtin and nuclear matrix. All tested compounds displaced 170-[3H]estradiol from the cytosolic amount per Leydig cell as estrogen treatment of susceptible mice continues over a 3-mo period and hyperplasia is initiated estrogen receptor, but to varying degrees; and there was no discernible (9).
    [Show full text]
  • NDA/BLA Multi-Disciplinary Review and Evaluation
    NDA/BLA Multi-disciplinary Review and Evaluation NDA 214154 Nextstellis (drospirenone and estetrol tablets) NDA/BLA Multi-Disciplinary Review and Evaluation Application Type NDA Application Number(s) NDA 214154 (IND 110682) Priority or Standard Standard Submit Date(s) April 15, 2020 Received Date(s) April 15, 2020 PDUFA Goal Date April 15, 2021 Division/Office Division of Urology, Obstetrics, and Gynecology (DUOG) / Office of Rare Diseases, Pediatrics, Urologic and Reproductive Medicine (ORPURM) Review Completion Date April 15, 2021 Established/Proper Name drospirenone and estetrol tablets (Proposed) Trade Name Nextstellis Pharmacologic Class Combination hormonal contraceptive Applicant Mayne Pharma LLC Dosage form Tablet Applicant proposed Dosing x Take one tablet by mouth at the same time every day. Regimen x Take tablets in the order directed on the blister pack. Applicant Proposed For use by females of reproductive potential to prevent Indication(s)/Population(s) pregnancy Recommendation on Approval Regulatory Action Recommended For use by females of reproductive potential to prevent Indication(s)/Population(s) pregnancy (if applicable) Recommended Dosing x Take one pink tablet (drospirenone 3 mg, estetrol Regimen anhydrous 14.2 mg) by mouth at the same time every day for 24 days x Take one white inert tablet (placebo) by mouth at the same time every day for 4 days following the pink tablets x Take tablets in the order directed on the blister pack 1 Reference ID: 4778993 NDA/BLA Multi-disciplinary Review and Evaluation NDA 214154 Nextstellis (drospirenone and estetrol tablets) Table of Contents Table of Tables .................................................................................................................... 5 Table of Figures ................................................................................................................... 7 Reviewers of Multi-Disciplinary Review and Evaluation ...................................................
    [Show full text]
  • Identification and Confirmation of the Environmental Risks of Emerging Pollutants in Surface Waters and Sediments
    Identification and confirmation of the environmental risks of emerging pollutants in surface waters and sediments Von der Fakultät für Mathematik, Informatik und Naturwissenschaften der RWTH Aachen University zur Erlangung des akademischen Grades eines Doktors der Naturwissenschaften genehmigte Dissertation Vorgelegt von Shangbo Zhou, Master of engineering aus Gansu, China Berichter: Univ.-Prof. Dr. rer. nat. Henner Hollert Univ.-Prof. Dr. rer. nat. Andreas Schäffer Tag der mündlichen Prüfung: 24.09.2019 Diese Dissertation ist auf den Internetseiten der Universitätsbibliothek online verfügbar. Your teacher can open the door but you must enter by yourself. – Chinese verb Abstract Although the occurrence, the fate and the toxicology of emerging pollutants in the aquatic environment have been widely studied, there is still a lack in the correlation of the levels of pollutants with the possible adverse effects in wildlife. The shortcomings of traditional methods for risk assessment have been observed, and the contributions of the identified compounds to the observed risks are rarely confirmed. Therefore, the main purpose of this thesis was to develop reasonable methods for risk identification of single compounds and mixtures, and to identify and confirm environmental risks caused by non-specific and mechanism-specific toxicity in aquatic systems. In this thesis, optimized methods for risk identification of single compounds and mixtures were developed. For screening-level risk assessment of single compounds, an optimized risk quotient that considers not only toxicological data but also the frequency with which the detected concentrations exceeded predicted no-effect concentrations was used to screen candidate priority pollutants in European surface waters. Results showed that 45 of the 477 analyzed compounds indicated potential risks for European surface waters.
    [Show full text]
  • November Packet
    L Buckman Dire cl Diversion Date: October 22,2018 To: Buckman Direct Diversion Board From: Michael Dozier, BDD Operations Superintendent .AAD Subject: Update on BDD Operations for the Month of October 2018 ITEM: 1. This memorandum is to update the Buckman Direct Diversion Board (BDDB) on BDD operations during the month of October 2018. The BDD diversions and deliveries have averaged, in Million Gallons Per Day (MOD) as follows: a. Raw water diversions: 5.66 MOD b. Drinking water deliveries through Booster Station 4N5A: 5.08 MOD c. Raw water delivery to Las Campanas at BS2A: 0.53 MOD d. Onsite treated and non-treated water storage: 0.05 MOD Average 2. The BDD is providing approximately 81% percent of the water supply to the City and County for the month. 3. The BDD year-to-date diversions are depicted below: Year-To-Date Comparison 350.00 , I ®.' Buckman Direct Diversion • 341 Caja del Rio Rd. • Santa Fe, NM 87506 1 4. Background Diversion tables: Buckman Direct Diversion Monthly SJC and Native Diversions Oct-18 In Acre-Feet Total SD-03418 SP-4842 SP-2847-E SP-2847-N-A All Partners SJC+ RGNative Month RG Native SJCCall SJCCall Conveyance Native LAS SJCCall COUNTY CITY LASCAMPANAS Losses Rights CAMPANAS Total JAN 380.137 77.791 0.000 302.346 302.346 0.000 3.023 FEB 336.287 66.413 0.000 269.874 169.874 0.000 2.699 MAR 362.730 266.898 0.000 95.832 95.832 0.000 0.958 APR 661.333 568.669 0.000 92.664 92.664 0.000 0.927 MAY 933.072 340.260 0.000 592.812 481.647 111.165 5.928 JUN 873.384 44.160 0.000 829.224 693.960 135.264 8.292 JUL 807.939
    [Show full text]
  • Anti-Obesity Therapy: from Rainbow Pills to Polyagonists
    1521-0081/70/4/712–746$35.00 https://doi.org/10.1124/pr.117.014803 PHARMACOLOGICAL REVIEWS Pharmacol Rev 70:712–746, October 2018 Copyright © 2018 The Author(s). This is an open access article distributed under the CC BY Attribution 4.0 International license. ASSOCIATE EDITOR: BIRGITTE HOLST Anti-Obesity Therapy: from Rainbow Pills to Polyagonists T. D. Müller, C. Clemmensen, B. Finan, R. D. DiMarchi, and M. H. Tschöp Institute for Diabetes and Obesity, Helmholtz Diabetes Center, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany (T.D.M., C.C., M.H.T.); German Center for Diabetes Research, Neuherberg, Germany (T.D.M., C.C., M.H.T.); Department of Chemistry, Indiana University, Bloomington, Indiana (B.F., R.D.D.); and Division of Metabolic Diseases, Technische Universität München, Munich, Germany (M.H.T.) Abstract ....................................................................................713 I. Introduction . ..............................................................................713 II. Bariatric Surgery: A Benchmark for Efficacy ................................................714 III. The Chronology of Modern Weight-Loss Pharmacology . .....................................715 A. Thyroid Hormones ......................................................................716 B. 2,4-Dinitrophenol .......................................................................716 C. Amphetamines. ........................................................................717 Downloaded from 1. Methamphetamine
    [Show full text]
  • Effects of Diethylstilbestrol on the Proliferation and Tyrosinase Activity of Cultured Human Melanocytes
    BIOMEDICAL REPORTS 3: 499-502, 2015 Effects of diethylstilbestrol on the proliferation and tyrosinase activity of cultured human melanocytes JIANBING TANG, QIN LI, BIAO CHENG, CHONG HUANG and KUI CHEN Department of Plastic Surgery, The Key Laboratory of Trauma Treatment and Tissue Repair of Tropical Area, People's Liberation Army, HuaBo BioPharmaceutical Institute of Guangzhou, General Hospital of Guangzhou Military Command, Guangzhou, Guangdong 510010, P.R. China Received March 13, 2015; Accepted April 24, 2015 DOI: 10.3892/br.2015.472 Abstract. The aim of the present study was to observe the with estrogen. The pigmented spot becomes more severe and effects of different exogenous estrogen diethylstilbestrol (DES) malignant melanoma proceeds rapidly during an abnormal concentrations on the human melanocyte proliferation and menstruation or pregnancy. There are changes in the estrogen tyrosinase activity. Skin specimens were obtained following level in these physiological processes. Therefore, estrogen blepharoplasty, and the melanocytes were primary cultured is considered an important factor that affects pigmented and passaged to the third generation. The melanocytes were diseases (1). Diethylstilbestrol (DES) is a synthetic nonsteroidal seeded in 96-well plates, each well had 5x103 cells. The medium estrogen that can produce the same pharmacological effects as was changed after 24 h, and contained 10-4-10 -8 M DES. After natural estrogen (2). In order to explore the mechanism, the the melanocytes were incubated, the proliferation and tyrosi- excess skin following eyelid blepharoplasty was collected for nase activity were detected by the MTT assay and L-DOPA melanocyte culture and different DES concentrations were reaction. DES (10-8-10 -6 M) enhanced the proliferation of used to detect the effect on the proliferation and tyrosinase cultured melanocytes.
    [Show full text]
  • 29 June 2016 09 :30 – 09 :55 : Registration 09 :55 – 10 :00 : Welcome 10 :00 – 10 :30 : the Unique Potential of Estetrol
    investor day 2016 29 June 2016 09 :30 – 09 :55 : Registration 09 :55 – 10 :00 : Welcome 10 :00 – 10 :30 : The unique potential of Estetrol 10 :30 – 11 :45Programme: Mithra’sde la journée strategy 11 :45 – 12 :00 : Q&A 12 :00 – 13 :30 : Drink and lunch with Executive Management 13 :30 – 14 :15 : Focus on Estetrol-based projects 14 :15 – 14 :30 : Coffee break 14 :30 – 15 :15 : Focus on long-acting drugs and Mithra CDMO 15 :15 – 15 :30 : Q&A and wrap-up session 15 :30 – 16 :30 : Drink and networking What is Estetrol ? Interview with Professor J.M. Foidart MD. Member of scientific committee Mithra Professor J.M. Foidart MD. Member of scientific committee Mithra 4 Estrogens in the “pill” a very limited family . Estradiol . Synthetic progestin . Ethinylestradiol Over 95% of oral contraceptives contain ethinylestradiol 6 Synthetic Progestins : a very large family First First Second Third New” COCs generation: generation: generation: progestins: > Norethisterone > Norethynodrel > Norgestrel > Desogestrel > Drospirenone > Norethinodrel > Nortestosterone > Levonorgestrel > Etonogestrel > Dienogest > High doses of derivatives > Gestodene > Trimestone synthetic estrogen >Pregnanes > Nesterone and androgenic > Norgestimate > Nomegestrol Ac. progestin > Promegestone Jan 2014 EMA classification progestins by type . Structural modification: to reduce androgenic side-effects but maintain strong progestational activity . Wider health benefits depending on progestin properties Reviewed in Brynhildsen J. Ther Adv Drug Saf. 2014;5(5):201-13; Benagiano7 G, et al. Eur J Contracept Reprod Health Care. 2004;9(3):182- 93; Sitruk-Ware R. Hum Reprod Update. 2006;12(2):169-78; Micks E, et al. Endocr Connect. 2015;4(4):R81-92 The third and fourth generation progestins and pills are not androgenic.
    [Show full text]